Skip to content
DraconiticResearch
Search Sources API
197,787 studies31 sourcesUpdated 30 min ago
Peer-reviewedLicence not statedPubMed

The Role of Exercise and Hyperlipidaemia in Breast Cancer Progression

  1. 1Univ Otago, Dept Pathol, Mackenzie Canc Res Grp, Christchurch, New Zealand
  2. 2Mackenzie Cancer Research Group; Department of Pathology; University of Otago; Christchurch New Zealand

Related

  1. CYB5R1 drives stemness and malignant progression via STAM2/STAT3 in chemotherapy-enriched triple-negative breast cancer
    Zhongyu Wang, Jia Li, Lin Geng +11
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  2. A stromal metabolic program suppresses NK-cell immunity to drive tumor progression in HER2-low breast cancer
    K. Carter, O. Ogunlusi, M. Sarkar +10
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. VCP-Regulated LMF2 Stabilizes the Cholesterol Biosynthesis Enzyme HMGCS1 to Drive Cancer Progression and Confer Capecitabine Resistance in Triple-Negative Breast Cancer.
    Qian Zhao, Lisa Andriani, Yin-Ling Zhang +10
    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Peer-reviewedCC BYFull textOncologyEurope PMC
  4. Breast cancer adaptation to oxygen stress: mechanisms of tumor survival, progression, and therapeutic resistance
    Emmanuel Ifeanyi Obeagu, Izuchukwu Hilary Edeoga
    Oncology reviewsPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  5. A spatial single-cell transcriptomic atlas of metastatic breast cancer progression
    Z. Dauyey, A. Velds, R. Gobits +17
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
BibTeX
@article{buss2026role,
  title = {{The Role of Exercise and Hyperlipidaemia in Breast Cancer Progression}},
  author = {Linda A. Buss and Gabi U. Dachs},
  journal = {PubMed},
  year = {2026},
  month = jul,
  doi = {10.22029/eir.2018.1717},
  url = {https://doi.org/10.22029/eir.2018.1717},
}
RIS
TY  - JOUR
TI  - The Role of Exercise and Hyperlipidaemia in Breast Cancer Progression
AU  - Linda A. Buss
AU  - Gabi U. Dachs
PY  - 2026
DA  - 2026/07/15
JO  - PubMed
DO  - 10.22029/eir.2018.1717
UR  - https://doi.org/10.22029/eir.2018.1717
ER  -